Hosted by Global STL, Datos was one of 14 companies invited from over 600 appliants to pitch their cutting-edge technologies to decision makers from St. Louis-area hospitals, corporations and venture capitalists looking to invest in new companies.

“We specifically select companies that represent compelling, high-value technology for St. Louis’ health care systems and corporations, come with proven track records, and have the ability to immediately enter the U.S market,” Donn Rubin, president and CEO of BioSTL, said in a statement.

Read the full article here